Enabling Sciences


The Enabling Sciences SWAT team provides cross-cutting support to COVID-19 vaccine developers in the area of diagnostics, standards, assays and animal models.

Clinical Development and Operations

The Clinical Development and Operations SWAT team collaborates on initiatives related to clinical operations (incl.  supporting trial site readiness and setting up a clinical trial site network, providing information ...

Manufacturing


The Manufacturing SWAT team provides cross-cutting support to COVID-19 vaccine developers in the area of Drug Substance (DS) and Drug Product (DP) scale-up and scale-out, supply chain and release assays.

Regulatory Advisory Group

The COVAX Regulatory Advisory Group works to address regulatory issues and challenges identified by the enabling sciences, clinical development and operations, and manufacturing SWAT teams.

CEPI, Gavi and the WHO are co-leading COVAX, with key delivery partner UNICEF, to accelerate the development and manufacture of COVID-19 vaccines, and to deliver fair and equitable access for every country in the world. COVAX is the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator.

COVAX is working to end the acute phase of the pandemic and support countries to achieve their individual vaccination goals through delivering fair, equitable access to vaccines for every country that participates. You can follow the latest global vaccination rollout through COVAX on our partner UNICEF’s website.


A joint newsletter of the COVAX SWAT Teams was compiled and distributed on a bi-weekly basis until March 2022.

Please find all editions of the newsletter below:

Earlier Editions  |  February 9, 2022  |  March 9, 2022